W S Griffin - JoVE Visualize

Showing results (61-70 of 80) with videos related to

Pageof 8

Sort By:

Proceedings of the National Academy of Sciences of the United States of America|October 1, 1989

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer diseaseW S Griffin, L C Stanley, C Ling, et al.

Acta Neurochirurgica. Supplement|January 1, 1996

Altered beta-APP metabolism after head injury and its relationship to the aetiology of Alzheimer's diseaseD I Graham, S M Gentleman, J A Nicoll, et al.

Journal of Neuropathology and Experimental Neurology|June 22, 1999

Increased interleukin-1beta converting enzyme expression and activity in Alzheimer diseaseS G Zhu, J G Sheng, R A Jones, et al.

Neurobiology of Aging|September 1, 1996

In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesisJ G Sheng, K Ito, R D Skinner, et al.

Neuropathology and Applied Neurobiology|November 17, 1999

Overexpression of s100beta in Down's syndrome: correlation with patient age and with beta-amyloid depositionM C Royston, J E McKenzie, S M Gentleman, et al.

Neurochemistry International|October 2, 2001

Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylationJ G Sheng, R A Jones, X Q Zhou, et al.

Neuroreport|April 14, 1997

A beta 42 is the predominant form of amyloid beta-protein in the brains of short-term survivors of head injuryS M Gentleman, B D Greenberg, M J Savage, et al.

Journal of Neuropathology and Experimental Neurology|May 1, 1994

Glial cytokines as neuropathogenic factors in HIV infection: pathogenic similarities to Alzheimer's diseaseL C Stanley, R E Mrak, R C Woody, et al.

Molecular and Chemical Neuropathology|April 1, 1996

Nitric oxide synthase (NOS) in schizophrenia: increases in cerebellar vermisC N Karson, W S Griffin, R E Mrak, et al.

Brain Pathology (Zurich, Switzerland)|February 11, 1998

Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progressionW S Griffin, J G Sheng, M C Royston, et al.

Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:

Pageof 8

Proceedings of the National Academy of Sciences of the United States of America|October 1, 1989

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer diseaseW S Griffin, L C Stanley, C Ling, et al.

Acta Neurochirurgica. Supplement|January 1, 1996

Altered beta-APP metabolism after head injury and its relationship to the aetiology of Alzheimer's diseaseD I Graham, S M Gentleman, J A Nicoll, et al.

Journal of Neuropathology and Experimental Neurology|June 22, 1999

Increased interleukin-1beta converting enzyme expression and activity in Alzheimer diseaseS G Zhu, J G Sheng, R A Jones, et al.

Neurobiology of Aging|September 1, 1996

In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesisJ G Sheng, K Ito, R D Skinner, et al.

Neuropathology and Applied Neurobiology|November 17, 1999

Overexpression of s100beta in Down's syndrome: correlation with patient age and with beta-amyloid depositionM C Royston, J E McKenzie, S M Gentleman, et al.

Neurochemistry International|October 2, 2001

Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylationJ G Sheng, R A Jones, X Q Zhou, et al.

Neuroreport|April 14, 1997

A beta 42 is the predominant form of amyloid beta-protein in the brains of short-term survivors of head injuryS M Gentleman, B D Greenberg, M J Savage, et al.

Journal of Neuropathology and Experimental Neurology|May 1, 1994

Glial cytokines as neuropathogenic factors in HIV infection: pathogenic similarities to Alzheimer's diseaseL C Stanley, R E Mrak, R C Woody, et al.

Molecular and Chemical Neuropathology|April 1, 1996

Nitric oxide synthase (NOS) in schizophrenia: increases in cerebellar vermisC N Karson, W S Griffin, R E Mrak, et al.

Brain Pathology (Zurich, Switzerland)|February 11, 1998

Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progressionW S Griffin, J G Sheng, M C Royston, et al.

Pageof 8